← All case studies

1 in 4 LinkedIn requests accepted for Biobot, eleven months running

LinkedIn outreach from three Biobot leaders to pharma and public health buyers, with conference email alongside it, from December 2025 to now.

  1. Connection requests4,246
  2. Accepted1,003
  3. Replies201
  4. Interested on LinkedIn72
  5. IDWeek opportunities37
Buyer
Vaccine, real-world evidence, clinical and marketing leaders
Market
Pharma, hospitals, public health
Channels
LinkedIn, email, Salesforce
Dates
Dec 2025 to now

About Biobot Analytics

Biobot Analytics tests wastewater to track respiratory illness, infectious disease and substance use in communities. The data often shows a trend weeks before it appears in clinical reporting.

Pharma marketing and vaccine teams use it to see where illness is rising. Hospitals and public health agencies use it to get ahead of outbreaks.

What we set out to do

  • Start conversations with the right people inside 13 priority pharma companies
  • Have that outreach come from Biobot's own leaders
  • Build a Salesforce setup to track every account and deal

The buyers sit in different teams, from vaccines and real-world evidence to clinical trials and marketing, and each team cares about the data for a different reason.

How we planned the outreach

We matched each Biobot sender to the buyers they would naturally talk to.

  • The co-founder and president wrote to senior leaders
  • The head of epidemiology wrote to epidemiology, data science and vaccine teams
  • The head of sales development wrote to marketing and commercial teams

Connection requests went out blank, which got more accepts from pharma than a pitch did. The first message only went out once someone accepted.

SegmentSent byResult
1
Pharma13 priority accounts, with four buyer types at each one.
Co-founderHead of epidemiologyHead of sales development
27.9% accepted24 interested from 119 replies
2
ConferencesWorld Vaccine Congress, RX Summit and IDWeek, with attendee and speaker lists built from public sources.
The leaders attending each show
28.1% accepted45 interested from 60 replies
3
HospitalsMassachusetts hospitals, from August to October 2026.
Head of sales development
11.9% accepted3 interested from 22 replies

LinkedIn results by segment, December 2025 to November 2026.

December 2025

LinkedIn went live to 13 pharma accounts from three Biobot senders.

February 2026

After the pilot review we kept going and started building conference plays for World Vaccine Congress and RX Summit.

October 2026

IDWeek email went out from three Biobot leaders, while hospital outreach ran at the same time.

37%

The head of epidemiology had the highest accept rate of any sender. An epidemiologist writing to epidemiologists got 99 of 267 requests accepted.

The IDWeek email

For IDWeek we built a list of 2,230 attendees from public sources and found 1,566 verified emails.

Three Biobot leaders who were going to the show emailed attendees in the two weeks before it. The email was two sentences with one ask: say hello in person.

Why it worked

  • It came from people who would actually be at the show
  • It asked for something small and easy to say yes to
  • The head of epidemiology's version got replies from 13.7% of the people it reached
IDWeek 2026, email 1Sent as written
FromBiobot leader attending IDWeek
To{{firstName}}, IDWeek attendee
Subjectidweek this week

{{firstName}} -- we'll be at IDWeek this week and would love to say hello if you're around and have a minute. Or happy to come find you.

Sent by

Co-founder and presidentCo-founderHead of epidemiology

What came back

8.7%of attendees replied
37opportunities

LinkedIn results, last 12 months

This is the LinkedIn dashboard in mid-October 2026, across every campaign and sender.

Biobot LinkedIn performanceLast 12 months
LinkedIn performance for Biobot over 12 months: 3,876 connections sent, 941 accepted (24.3%), 193 replied (26.7%), 69 interested
  1. 24.3% of connection requests accepted
  2. 26.7% of messaged leads replied
  3. 69 interested leads

By November the totals had reached 4,246 requests, 1,003 accepted, 201 replies and 72 interested leads. The engagement is ongoing.

Selling into pharma or life sciences?

We build the lists, write the messages, run outreach from your own people and connect it to your CRM, starting with a four-month pilot.

Book a discovery session →
Next: Iris Booth →